Atlas Trials

Selexipag for the Treatment of Schistosomiasis-Associated Pulmonary Arterial Hypertension

Clinical trial NCT04589390 · UNKNOWN

Trial details

NCT number
NCT04589390
Sponsor
University of Sao Paulo General Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Pulmonary HypertensionSchistosomiasis
Start date
2020-10-15
Primary completion
2021-11-30
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.